Global Ocular Implants Market 2022-2026

Description

List of Tables

Technavio has been monitoring the ocular implants market and it is poised to grow by $1.82 bn during 2022-2026, accelerating at a CAGR of 7.26% during the forecast period. Our report on the ocular implants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of ophthalmic diseases, technological advances, and increasing access to ocular implants in emerging markets.

The ocular implants market analysis includes product segment and geographic landscape.

Technavio's ocular implants market is segmented as below:

By Product

IOLs
Corneal implants
Glaucoma implants
Ocular prostheses

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies custom-made ocular prostheses as one of the prime reasons driving the ocular implant market growth during the next few years. Also, increasing preference for ASCS over hospitals for ophthalmology procedures and increasing medical tourism for cataract surgery will lead to sizable demand in the market.

Technavio presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters. Our report on the ocular implants market covers the following areas:

Ocular implants market sizing
Ocular implants market forecast
Ocular implants market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ocular implants market vendors that include AJL Ophthalmic SA, Bausch Health Companies Inc., Becton Dickinson, and Co., Care Group Sight Solution Pvt. Ltd., Carl Zeiss AG, CorNeat Vision Ltd, EyeD Pharma s.a., F.AD. Muller Sohne GmbH and Co. KG, Glaukos Corp, Gulden Ophthalmics, HOYA Corp., HumanOptics Holding AG, Johnson and Johnson, Morcher GmbH, NIDEK Co. Ltd, Novartis AG, Omni Lens Pvt Ltd, Ophtec BV, Rayner Intraocular Lenses Ltd., and Second Sight Medical Products Inc. Also, the ocular implants market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all future growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR74296

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

5.1 Market segments
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
5.2 Comparison by Product
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
5.3 IOLs - Market size and forecast 2021-2026
Exhibit 28: Chart on IOLs - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on IOLs - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on IOLs - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on IOLs - Year-over-year growth 2021-2026 (%)
5.4 Corneal Implants - Market size and forecast 2021-2026
Exhibit 32: Chart on Corneal Implants - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Corneal Implants - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Corneal Implants - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Corneal Implants - Year-over-year growth 2021-2026 (%)
5.5 Glaucoma Implants - Market size and forecast 2021-2026
Exhibit 36: Chart on Glaucoma Implants - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Glaucoma Implants - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Glaucoma Implants - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Glaucoma Implants - Year-over-year growth 2021-2026 (%)
5.6 Ocular prostheses - Market size and forecast 2021-2026
Exhibit 40: Chart on Ocular prostheses - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Ocular prostheses - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Ocular prostheses - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Ocular prostheses - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Product
Exhibit 44: Market opportunity by Product ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 France - Market size and forecast 2021-2026
Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 UK - Market size and forecast 2021-2026
Exhibit 82: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 AJL Ophthalmic SA
Exhibit 93: AJL Ophthalmic SA - Overview
Exhibit 94: AJL Ophthalmic SA - Product / Service
Exhibit 95: AJL Ophthalmic SA - Key offerings
10.4 Bausch Health Companies Inc.
Exhibit 96: Bausch Health Companies Inc. - Overview
Exhibit 97: Bausch Health Companies Inc. - Business segments
Exhibit 98: Bausch Health Companies Inc. - Key news
Exhibit 99: Bausch Health Companies Inc. - Key offerings
Exhibit 100: Bausch Health Companies Inc. - Segment focus
10.5 Carl Zeiss AG
Exhibit 101: Carl Zeiss AG - Overview
Exhibit 102: Carl Zeiss AG - Business segments
Exhibit 103: Carl Zeiss AG - Key offerings
Exhibit 104: Carl Zeiss AG - Segment focus
10.6 EyeD Pharma s.a.
Exhibit 105: EyeD Pharma s.a. - Overview
Exhibit 106: EyeD Pharma s.a. - Product / Service
Exhibit 107: EyeD Pharma s.a. - Key offerings
10.7 Gulden Ophthalmics
Exhibit 108: Gulden Ophthalmics - Overview
Exhibit 109: Gulden Ophthalmics - Product / Service
Exhibit 110: Gulden Ophthalmics - Key offerings
10.8 Johnson and Johnson
Exhibit 111: Johnson and Johnson - Overview
Exhibit 112: Johnson and Johnson - Business segments
Exhibit 113: Johnson and Johnson - Key news
Exhibit 114: Johnson and Johnson - Key offerings
Exhibit 115: Johnson and Johnson - Segment focus
10.9 Morcher GmbH
Exhibit 116: Morcher GmbH - Overview
Exhibit 117: Morcher GmbH - Product / Service
Exhibit 118: Morcher GmbH - Key offerings
10.10 NIDEK Co. Ltd
Exhibit 119: NIDEK Co. Ltd - Overview
Exhibit 120: NIDEK Co. Ltd - Business segments
Exhibit 121: NIDEK Co. Ltd - Key news
Exhibit 122: NIDEK Co. Ltd - Key offerings
Exhibit 123: NIDEK Co. Ltd - Segment focus
10.11 Novartis AG
Exhibit 124: Novartis AG - Overview
Exhibit 125: Novartis AG - Business segments
Exhibit 126: Novartis AG - Key offerings
Exhibit 127: Novartis AG - Segment focus
10.12 Second Sight Medical Products Inc.
Exhibit 128: Second Sight Medical Products Inc. - Overview
Exhibit 129: Second Sight Medical Products Inc. - Product / Service
Exhibit 130: Second Sight Medical Products Inc. - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 131: Inclusions checklist
Exhibit 132: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 133: Currency conversion rates for US$
11.4 Research methodology
Exhibit 134: Research methodology
Exhibit 135: Validation techniques employed for market sizing
Exhibit 136: Information sources
11.5 List of abbreviations
Exhibit 137: List of abbreviations